Metadata
Title
Jason Roberts
Category
general
UUID
4d6a72d35a1f455794d323047661e3e7
Source URL
https://about.uq.edu.au/experts/1526
Parent URL
https://about.uq.edu.au/faculties-institutes/hmbs/about/leaders
Crawl Time
2026-03-11T06:58:40+00:00
Rendered Raw Markdown

Jason Roberts

Source: https://about.uq.edu.au/experts/1526 Parent: https://about.uq.edu.au/faculties-institutes/hmbs/about/leaders

Professor

Jason Roberts

Email: : j.roberts@uq.edu.au

Phone: : +61 7 334 66074

Positions

Affiliate of Centre for Extracellular Vesicle Nanomedicine : Centre for Extracellular Vesicle Nanomedicine : Faculty of Health, Medicine and Behavioural Sciences

Centre Director of UQ Centre for Clinical Research : UQ Centre for Clinical Research : Faculty of Health, Medicine and Behavioural Sciences

Affiliate of Queensland Cerebral Palsy Rehabilitation and Research Centre : Queensland Cerebral Palsy Rehabilitation and Research Centre : Faculty of Health, Medicine and Behavioural Sciences

Director, UQ Centre for Clinical Research : Faculty of Health, Medicine and Behavioural Sciences

NHMRC Leadership Fellow : Faculty of Health, Medicine and Behavioural Sciences

Overview

Background

Professor Jason Roberts is Director of the University of Queensland Centre for Clinical Research (UQCCR), an Australian National Health and Medical Research Council (NHMRC) Leadership Fellow L2 at The University of Queensland. He is also a Consultant Clinical Pharmacist at the Royal Brisbane and Women’s Hospital and Interim Director of the Herston Infectious Diseases Institute (HeIDI). He is Director of the NHMRC-funded Centre for Research Excellence RESPOND which is based at UQCCR. He is a clinician-scientist with a strong interest in research and his principal research theme is optimization of antimicrobial dosing in the critically ill. Prof Roberts has authored over 650 published papers and book chapters on this topic, has been awarded over $55 million in grants and has supervised >20 PhD students to completion.

Prof Roberts was recognised as Australia’s leading researcher in two separate categories, Critical Care and Communicable Diseases, by the Australian’s 2019 Research Magazine.

He has been invited to present his results at major international conferences in critical care, infectious diseases, pharmacy, nephrology, transplant and safety. He has served on the Critical Review Panel for ATS/IDSA Guidelines of HAP, HCAP and VAP and the Australian Therapeutic Guidelines - Antibiotic and the 2021 Surviving Sepsis Guidelines. He is the Past Chair of the Working Group for Antimicrobial Use in ICU for the European Society of Intensive Care Medicine and an Executive Member of the PK/PD Group (EPASG) within the European Society for Clinical Microbiology and Infectious Diseases (ESCMID).

He is Section Editor for the International Journal of Antimicrobial Agents and an Associate Editor of the Journal or Pharmacy Practice and Research, the journal for the Society of Hospital Pharmacists of Australia and an Associate Editor for Pharmacotherapy and Aanesthesiology Pain and Critical Care Medicine journal. He has convened >50 seminars/conferences including being co-convenor for Medicines Management 2013, The National Conference for Society of Hospital Pharmacists of Australia.

He also engages with Industry to perform studies that develop optimised antibiotic dosing regimens that maximise antibiotic efficacy for testing in clinical trials or for use in special patient populations (e.g. critically ill, pneumonia, dialysis).

Read more Read less

Availability

Professor Jason Roberts is: : Available for supervision : Media expert

Fields of research

Clinical sciences Pharmacology and pharmaceutical sciences

Qualifications

Works

Search Professor Jason Roberts’s works on UQ eSpace

All (879) Book (2) Journal Article (794) Other Outputs (2) Conference Publication (54) Book Chapter (27)

2026

Journal Article

Effect of ibuprofen on the pharmacokinetics of intravenous flucloxacillin in healthy adults

Boast, Alison, Legg, Amy, McCarthy, James, Roberts, Jason A, Tong, Stephen YC, Duffull, Stephen and Gwee, Amanda (2026). Effect of ibuprofen on the pharmacokinetics of intravenous flucloxacillin in healthy adults. International Journal of Antimicrobial Agents, 67 (2) 107684, 107684-2. doi: 10.1016/j.ijantimicag.2025.107684

Effect of ibuprofen on the pharmacokinetics of intravenous flucloxacillin in healthy adults

2026

Journal Article

A systematic review and meta-analysis of the global epidemiology of carbapenem-resistant Escherichia coli

Walker, Mikaela M., Li, Yixuan, Roberts, Jason A. and Sime, Fekade B. (2026). A systematic review and meta-analysis of the global epidemiology of carbapenem-resistant Escherichia coli. International Journal of Antimicrobial Agents, 67 (1) 107668, 1-8. doi: 10.1016/j.ijantimicag.2025.107668

A systematic review and meta-analysis of the global epidemiology of carbapenem-resistant Escherichia coli

2026

Journal Article

An easy-to-use predictive score for identifying patients at risk of suboptimal linezolid exposure and candidates for therapeutic drug monitoring

Fresán, Daniel, Sorlí, Luisa, Barceló-Vidal, Jaume, Rodrigo-Moreno, Ana, Muñoz, Rosana, Subirana, Isaac, Ferrer, Antoni, Velasco, Camila, Roberts, Jason, Benítez-Cano, Adela and Luque, Sonia (2026). An easy-to-use predictive score for identifying patients at risk of suboptimal linezolid exposure and candidates for therapeutic drug monitoring. International Journal of Antimicrobial Agents, 67 (1) 107661, 107661. doi: 10.1016/j.ijantimicag.2025.107661

An easy-to-use predictive score for identifying patients at risk of suboptimal linezolid exposure and candidates for therapeutic drug monitoring

2026

Book Chapter

Principles of antimicrobial use in the intensive care unit

Ulldemolins, Marta, Roberts, Jason A. and Lipman, Jeffrey (2026). Principles of antimicrobial use in the intensive care unit. Oh's Intensive Care Manual. (pp. 162-168) Amsterdam, Netherlands: Elsevier. doi: 10.1016/b978-0-443-11611-7.00020-7

Principles of antimicrobial use in the intensive care unit

2025

Journal Article

Prolonged versus intermittent beta-lactam antibiotic infusions in paediatric critical care: a systematic review and meta-analysis

Okeefe, Kirsty, Denny, Kerina J., Le Marsney, Renate, Mccullough, James, Gilholm, Patricia, Budai, Kinga A., Beranger, Agathe, Lodi, Csaba, Obeidat, Mahmoud, Ragonnet, Gwendoline, Wacharachaisurapol, Noppadol, Roberts, Jason A., Gibbons, Kristen S. and Raman, Sainath (2025). Prolonged versus intermittent beta-lactam antibiotic infusions in paediatric critical care: a systematic review and meta-analysis. Journal of Paediatrics and Child Health jpc.70275. doi: 10.1111/jpc.70275

Prolonged versus intermittent beta-lactam antibiotic infusions in paediatric critical care: a systematic review and meta-analysis

2025

Journal Article

A Pharmacokinetic Analysis of Intravenous Fluconazole in Adult Patients Undergoing Mechanical Circulatory Support Device Implantation

Cairns, Kelly A., Hernandez-Mitre, Maria Patricia, Peel, Trisha N., Abbott, Iain J., Kaye, David M., Marasco, Silvana, Daly, David, Warner, Victoria, Coldham, Anna, Pope, Jeffrey D., Schneider, Hans G, Dooley, Michael J., Liu, Xin, Roberts, Jason A. and Udy, Andrew A. (2025). A Pharmacokinetic Analysis of Intravenous Fluconazole in Adult Patients Undergoing Mechanical Circulatory Support Device Implantation. Clinical Pharmacokinetics, 1-10. doi: 10.1007/s40262-025-01607-z

A Pharmacokinetic Analysis of Intravenous Fluconazole in Adult Patients Undergoing Mechanical Circulatory Support Device Implantation

2025

Journal Article

Antibacterial pharmacokinetics in critically ill patients receiving extracorporeal membrane oxygenation (ECMO): a systematic review of population pharmacokinetic studies

Ren, Chanelle, Huang, Frank, Cheng, Vesa, Xie, Jiao, Roberts, Jason A and Abdul-Aziz, Mohd H (2025). Antibacterial pharmacokinetics in critically ill patients receiving extracorporeal membrane oxygenation (ECMO): a systematic review of population pharmacokinetic studies. Clinical pharmacokinetics PMID 7606849. doi: 10.1007/s40262-025-01596-z

Antibacterial pharmacokinetics in critically ill patients receiving extracorporeal membrane oxygenation (ECMO): a systematic review of population pharmacokinetic studies

2025

Journal Article

Peri-Operative Dosage and Therapeutic Concentrations of Cefazolin Administered for Surgical Site Infection Prophylaxis in Elective Surgery—A Systematic Review

Ryan, Rochelle, Bosnak, Cemre, Bright, Matthew, Cheng, Vesa, Velli, Gina, van Zundert, Andre, Lipman, Jeffrey and Roberts, Jason A. (2025). Peri-Operative Dosage and Therapeutic Concentrations of Cefazolin Administered for Surgical Site Infection Prophylaxis in Elective Surgery—A Systematic Review. Antibiotics, 14 (12) 1227, 1227. doi: 10.3390/antibiotics14121227

Peri-Operative Dosage and Therapeutic Concentrations of Cefazolin Administered for Surgical Site Infection Prophylaxis in Elective Surgery—A Systematic Review

2025

Journal Article

Population pharmacokinetics and optimized dosing of piperacillin-tazobactam in hematological patients with febrile neutropenia

Laporte-Amargos, Julia, Ulldemolins, Marta, Hernández-Mitre, María Patricia, Roberts, Jason A., Rigo-Bonnin, Raul, Carmona-Torre, Francisco, Huguet, Maria, Puerta-Alcalde, Pedro, Arnan, Montserrat, del Pozo, Jose Luis, Torrent, Anna, García-Vidal, Carolina, Sureda, Anna, Bergas, Alba, Sastre-Escolà, Enric, Carratalà, Jordi and Gudiol, Carlota (2025). Population pharmacokinetics and optimized dosing of piperacillin-tazobactam in hematological patients with febrile neutropenia. Antimicrobial Agents and Chemotherapy, 70 (1) e01253-25, 1-13. doi: 10.1128/aac.01253-25

Population pharmacokinetics and optimized dosing of piperacillin-tazobactam in hematological patients with febrile neutropenia

2025

Journal Article

Factors affecting voriconazole pharmacokinetic variability in critically ill patients: a systematic review

Coste, Anne, Aubron, Cécile, Ansart, Séverine, Roberts, Jason, Morio, Florent and Grégoire, Matthieu (2025). Factors affecting voriconazole pharmacokinetic variability in critically ill patients: a systematic review. Critical Care, 29 (1) 536, 1. doi: 10.1186/s13054-025-05697-w

Factors affecting voriconazole pharmacokinetic variability in critically ill patients: a systematic review

2025

Journal Article

Convalescent plasma in hospitalised patients with COVID-19

Mcquilten, Zoe, O'sullivan, Matthew V. N., Purcell, Damien, Edler, Peta, Meagher, Niamh, Alcorn, Kylie, Bowen, Asha, Daly, James, Foo, Hong, Goulding, Susan, Gosbell, Iain, Hammond, Naomi, Hills, Thomas, Hoad, Veronica, Jha, Vivekanand, Lim, Lyn Li, Mcphee, Grace, Molton, James, Morpeth, Susan, Nguyen, Vi, Paterson, David, Rees, Megan, Roberts, Jason, Rogers, Benjamin A., Stewart, Adam, Sasadeusz, Joe, Snelling, Thomas, Venkatesh, Balasubramanian, Wood, Erica ... Denholm, Justin T. (2025). Convalescent plasma in hospitalised patients with COVID-19. Internal Medicine Journal, 55 (12) imj.70253, 2024-2032. doi: 10.1111/imj.70253

Convalescent plasma in hospitalised patients with COVID-19

2025

Journal Article

The impact of an ex vivo pediatric extracorporeal membrane oxygenation circuit on sequestration of antimicrobials

Cree, Michele L., Abdul-Aziz, Mohd Hafiz, Haisz, Emma, Wallis, Steven C., Won, Hayoung, Sumi, Chandra D., Marjanovic, Dusan, Ordóñez, Jenny L., Schlapbach, Luregn J. and Roberts, Jason A. (2025). The impact of an ex vivo pediatric extracorporeal membrane oxygenation circuit on sequestration of antimicrobials. Critical Care Explorations, 7 (11) e1338, e1338. doi: 10.1097/CCE.0000000000001338

The impact of an ex vivo pediatric extracorporeal membrane oxygenation circuit on sequestration of antimicrobials

2025

Journal Article

Antibiotic residual drug error in the intensive care unit: A qualitative exploration of awareness, causes, and solutions

Jarrett, Paul, Coyer, Fiona M., Long, Debbie, Roberts, Jason A. and Keogh, Samantha (2025). Antibiotic residual drug error in the intensive care unit: A qualitative exploration of awareness, causes, and solutions. Australian Critical Care, 38 (6) 101450, 101450-6. doi: 10.1016/j.aucc.2025.101450

Antibiotic residual drug error in the intensive care unit: A qualitative exploration of awareness, causes, and solutions

2025

Journal Article

Meropenem dosing optimization on day 1 and steady state in critically ill patients without significant renal impairment

Sulaiman, Helmi, Rozali, Muhammad Azrai, Adiraju, Santosh K. S., Hasan, M. Shahnaz, Jamal, Janattul A., Liu, Xin, Mat-Nor, Mohd-Basri, Mazlan, Mohd Zulfakar, Othman-Jailani, Mohamad Irfan, Salmuna, Zeti Norfidiyati, Wallis, Steven C., Roberts, Jason A. and Abdul-Aziz, Mohd H. (2025). Meropenem dosing optimization on day 1 and steady state in critically ill patients without significant renal impairment. Scientific Reports, 15 (1) 37781, 1-12. doi: 10.1038/s41598-025-20630-5

Meropenem dosing optimization on day 1 and steady state in critically ill patients without significant renal impairment

2025

Journal Article

Population pharmacokinetics of cefazolin administered as prophylaxis in paediatric patients undergoing cardiac surgery

Cheng, Vesa, Suna, Jessica, Liu, Xin, Moloney, Gregory, Marathe, Supreet P., Parker, Suzanne, Ungerer, Jacobus P. J., McWhinney, Brett, Venugopal, Prem, Alphonso, Nelson and Roberts, Jason A. (2025). Population pharmacokinetics of cefazolin administered as prophylaxis in paediatric patients undergoing cardiac surgery. Anaesthesia, critical care & pain medicine 101653, 101653. doi: 10.1016/j.accpm.2025.101653

Population pharmacokinetics of cefazolin administered as prophylaxis in paediatric patients undergoing cardiac surgery

2025

Journal Article

Beyond the numbers: do nomograms capture the complexity of RRT dosing? Author’s reply

Colmenero, Manuel, Roberts, Jason A., Lipman, Jeffrey and Ulldemolins, Marta (2025). Beyond the numbers: do nomograms capture the complexity of RRT dosing? Author’s reply. Intensive Care Medicine, 51 (11), 2170-2171. doi: 10.1007/s00134-025-08160-0

Beyond the numbers: do nomograms capture the complexity of RRT dosing? Author’s reply

2025

Journal Article

Efficacy, safety, and population pharmacokinetics of a single 1500mg dose of dalbavancin for short-term therapy in patients with chronic prosthetic joint infections

Benavent, Eva, Lora-Tamayo, Jaime, Ulldemolins, Marta, Pons-Oltra, Paula, Gregoire, Matthieu, Mancheno-Losa, Mikel, Hernandez-Jimenez, Pilar, Melendez-Carmona, M. Angeles, Casals, Victor, Roberts, Jason A., Rigo-Bonnin, Raul and Murillo, Oscar (2025). Efficacy, safety, and population pharmacokinetics of a single 1500mg dose of dalbavancin for short-term therapy in patients with chronic prosthetic joint infections. Antimicrobial Agents and Chemotherapy, 69 (12) e00773-25, e0077325. doi: 10.1128/aac.00773-25

Efficacy, safety, and population pharmacokinetics of a single 1500mg dose of dalbavancin for short-term therapy in patients with chronic prosthetic joint infections

2025

Journal Article

Implementation of outpatient parenteral antimicrobial therapy program in the contemporary health care system: A narrative review of the evidence

Mohammed, Solomon Ahmed, Roberts, Natasha, Nicolás, David, Unwin, Sean, Cotta, Menino, Roberts, Jason A. and Sime, Fekade B. (2025). Implementation of outpatient parenteral antimicrobial therapy program in the contemporary health care system: A narrative review of the evidence. Journal of Infection and Public Health, 18 (10) 102938, 102938. doi: 10.1016/j.jiph.2025.102938

Implementation of outpatient parenteral antimicrobial therapy program in the contemporary health care system: A narrative review of the evidence

2025

Journal Article

Phase 1, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of the safety, tolerability, and pharmacokinetics of intravenous xeruborbactam (QPX7728) in healthy adult subjects

Hernandez-Mitre, Maria Patricia, Wallis, Steven C., Loutit, Jeffery S., Griffith, David C. and Roberts, Jason A. (2025). Phase 1, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of the safety, tolerability, and pharmacokinetics of intravenous xeruborbactam (QPX7728) in healthy adult subjects. Antimicrobial Agents and Chemotherapy, 69 (10) e00784-25, e0078425. doi: 10.1128/aac.00784-25

Phase 1, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of the safety, tolerability, and pharmacokinetics of intravenous xeruborbactam (QPX7728) in healthy adult subjects

2025

Journal Article

International Network of Antibiotic Allergy Nations (iNAAN): protocol for a type 2 hybrid effectiveness-implementation multicentre prospective cohort and target trial emulation study evaluating penicillin allergy delabeling via direct oral challenge

Mitri, Elise A., Fletcher, Luke R., Paynter, Camille, Vogrin, Sara, James, Fiona, Ng, Irvin, Holmes, Natasha E., Ierano, Courtney, Roberts, Jason A., Fernando, Suran L., Klaic, Marlena and Trubiano, Jason A. (2025). International Network of Antibiotic Allergy Nations (iNAAN): protocol for a type 2 hybrid effectiveness-implementation multicentre prospective cohort and target trial emulation study evaluating penicillin allergy delabeling via direct oral challenge. PLOS ONE, 20 (9) e0330724, 1-14. doi: 10.1371/journal.pone.0330724

International Network of Antibiotic Allergy Nations (iNAAN): protocol for a type 2 hybrid effectiveness-implementation multicentre prospective cohort and target trial emulation study evaluating penicillin allergy delabeling via direct oral challenge

Funding

Current funding

Translating precision antibiotic dosing into better outcomes for severe infections

NHMRC Investigator Grants

Open grant - 2025 - 2026

Quality Medication Care Research UQ Centre for Clinical Research

Quality Medication Care Pty Ltd

Open grant - 2025 - 2030

Comparison of Continuous and Extended vs Intermittent Beta-Lactam Infusions in Critically Ill Children with Sepsis - the BUILD Multicentre Binational Randomised Controlled Trial

NHMRC MRFF CTA - Clinical Trials Activity

Open grant - 2025 - 2030

Integrating sequencing technologies for bloodstream infection and sepsis diagnostics in critically-ill patients

NHMRC MRFF Genomics Health Futures Mission

Open grant - 2025 - 2027

Beta-lactam Antibiotic Infusions in Septic Critically Ill Children - A Pilot Randomised Controlled Trial (BUILD)

Intensive Care Foundation

Open grant - 2025 - 2030

ROAD RCT: Resistance Optimised Antibiotic Dosing in critically ill patients - a Randomised Controlled Trial

NHMRC MRFF CTA - Clinical Trials Activity

Open grant - 2025 - 2026

Optimising antibiotic dosing in the Staphylococcus aureus Network Adaptive Platform trial (O-SNAP)

Metro North Hospital and Health Service

Open grant - 2024 - 2026

Establishing the pharmacokinetic profiles of Elexacaftor, Tezacaftor & Ivacaftor (Trikafta) in patients with Cystic Fibrosis to allow for therapeutic drug monitoring

Metro North Hospital and Health Service

Open grant - 2024 - 2026

Effect of uraemic gut on absorption profile of oral tacrolimus (2024 SERTA administered by MNHHS RBWH)

Metro North Hospital and Health Service

Open grant - 2024 - 2028

Unlocking the gut microbiome to track the spread of AMR genes and pathogens

MRFF - Global Health Initiative

Open grant - 2024 - 2028

Antithrombotic therapy to ameliorate clinical complications in community acquired pneumonia (ATTACC-CAP)

Monash University

Open grant - 2023 - 2028

OPTIMAL: OPTimising Immunoglobulin Management in Australia (NHMRC 2023 CRE administered by Monash University)

Monash University

Open grant - 2023 - 2026

Fentanyl use by nebuliser in labour - the FUN Study (ANZCA Grant led by MNHHS)

Metro North Hospital and Health Service

Open grant - 2023 - 2028

Building the next mRNA vaccines and therapies

MRFF - National Critical Infrastructure Initiative

Open grant - 2023 - 2027

Pharmacogenomics for better treatment of fungal infections in cancer

MRFF Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists

Open grant - 2022 - 2026

A coordinated multiplatform randomised trial for hospitalised patients with COVID-19 (Led by Monash University)

Monash University

Open grant - 2022 - 2026

Translating precision antibiotic dosing into better outcomes for severe infections

NHMRC Investigator Grants

Open grant - 2021 - 2026

Centre of Research Excellence - REduce the burden of antimicrobial reSistance through oPtimal, persONalised Dosing (RESPOND)

NHMRC Centres of Research Excellence

Open grant - 2021 - 2026

Testing a sinonasal microbiome transplant as a therapy for Chronic Rhinosinusitis by randomised controlled trial

NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need

Open grant - 2019 - 2026

Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMAT)

Cystic Fibrosis Foundation USA

Open grant - 2018 - 2026

Multi-drug resistant non-tuberculous mycobacteria infection research

Research Donation Generic

Open grant

View all 21 current funded projects View less

Past funding

Determining bEta-lactam Exposure targets in Patients with deep-seated infections. The DEEP Study (an observational PK-PD pilot study) (TPCHF Common Good Grant led by Metro North HHS)

Metro North Hospital and Health Service

Open grant - 2024 - 2025

Optimising intraoperative coagulation management for precision vascular surgery (externally administered by Metro North Health and Hospital Service)

TPCH Foundation Innovation Grants

Open grant - 2023 - 2025

A prospective observational comparative plasma and cerebrospinal fluid pharmacokinetics of levetiractam in aneursymal subarachoid haemorrhage and traumatic brain injury (The ALLEVIATE STUDY)

Metro North Hospital and Health Service

Open grant - 2023 - 2024

Development and clinical integration of a novel precision dosing software application to improve antimicrobial dosing in critically ill patients

Heidi-CSIRO IDR and AMR Projects

Open grant - 2023

Screening Antifungal Exposure in Intensive Care Units: The SAFE-ICU Study

Gilead Australia Fellowship

Open grant - 2022 - 2023

CAPJI RETRO-Research Support

Metro North Hospital and Health Service

Open grant - 2022 - 2023

Pharmacokinetic profile and breastmilk excretion of sugammadex in pregnant women (ANZCA grant administered by Metro North HHS)

Metro North Hospital and Health Service

Open grant - 2022 - 2025

Parkinson's Disease Bequest - Collaborative proposal, RN support

Research Donation Generic

Open grant - 2022 - 2023

Prospective, Open-Label, Randomized Control Trial on Pharmacokinetics of Direct Oral Anticoagulant (Apixaban) in Prevention of Primary Nephrotic Syndrome Associated Thromboembolic Disease (RBWH admin)

Metro North Hospital and Health Service

Open grant - 2022 - 2023

Evaluation of the stability of Aciclovir in elastomeric infusion devices used for Outpatient Parenteral Antimicrobial Therapy in accordance with the requirement of the UK NHS Yellow Cover Document

British Society for Antimicrobial Chemotherapy

Open grant - 2022 - 2023

The effects of renal replacement therapy on immunosuppressive drug concentrations (RWBH and RBWH Foundation Research Project Grant administered by QUT)

Queensland University of Technology

Open grant - 2022 - 2023

CT-Perfusion for neurological diagnostic evaluation: a prospective Canadian multicenter diagnostic test study

Centre Hospitalier de l'Universite de Montreal

Open grant - 2022

Comparative pharmacokinetics of nebulised and intravenous ketamine and dexmedetomidine in ventilated patients

Australian and New Zealand College of Anaesthestists

Open grant - 2021 - 2023

Continuous vs intermittent infusion of beta-lactam antibacterial drugs: impact on resistance and outcomes in sepsis - PMWP 170

United States Food and Drug Administration

Open grant - 2021 - 2022

A prospective observational study to describe the population pharmacokinetics of olanzapine and quetiapine in critically ill patients with delirium (PARANOID)

Melbourne Health

Open grant - 2021

Evaluation of the stability of Aciclovir in elastomeric infusion devises used in Outpatient Parenteral Antimicrobial Therapy in accordance with the requirement of the UK NHS Yellow Cover Document

British Society for Antimicrobial Chemotherapy

Open grant - 2021 - 2022

Evaluation of the stability of Amoxicillin in elastomeric infusion devices used for Outpatient Parenteral Antimicrobial Therapy in accordance with the requirement of the UK NHS Yellow Cover Document

British Society for Antimicrobial Chemotherapy

Open grant - 2021 - 2025

Pharmacokinetics of antimicrobials in paediatric patients on extracorporeal therapies (APET-PK)

Children's Health Queensland Hospital and Health Service

Open grant - 2021 - 2022

PIMS Study: An investigation of the utility of Microsampling versus traditional blood sampling for antibiotic pharmacokinetics in Children (SCHS Wishlist Foundation grant administered by SCHHS

Sunshine Coast Hospital and Health Service

Open grant - 2021

Optimising Cefazolin and Ceftriaxone Dosing in Australian Indigenous patients Requiring Intermittent Haemodialysis (Collaborative Research Project led by Flinders University)

Flinders University

Open grant - 2021 - 2022

Optimising dosing regimens of antimicrobials in critically ill children on extracorporeal membrane oxygenation (ECMO)

Preclinical and Clinical Early Career Research

Open grant - 2021 - 2025

OctapeptinX Potentiators to treat XDR Gram-negative infections

NHMRC Development Grant

Open grant - 2020 - 2021

The effect of extracorporeal membrane oxygenation (ECMO) on the effectiveness of Coronavirus Disease 2019 (COVID-19) pharmacotherapy - ex vivo characterisation and quantification [...]

Metro North Hospital and Health Service

Open grant - 2020 - 2021

Evaluation of the stability of Temocillin in elastomeric infusion devices used for Outpatient Parenteral Antimicrobial Therapy in accordance with the requirement of the UK NHS Yellow Cover Document

British Society for Antimicrobial Chemotherapy

Open grant - 2020

Dose optimization and clinical drug testing for Ivermectin

Monash University

Open grant - 2020 - 2024

Optimising antibiotic dosing for critically ill patients

Queensland Advancing Clinical Research Fellowship

Open grant - 2020 - 2021

USE OF THERAPEUTIC DRUG MONITORING (TDM) TO OPTIMISE ORAL/ENTERAL HYDROXYCHLOROQUINE DOSING IN CRITICALLY ILL PATIENTS WITH COVID-19 (MRFF CRR Respiratory Medicine administered by QUT)

Queensland University of Technology

Open grant - 2020

Rapid detection of resistance genes from Gram-negative bacteria isolated from blood in ICU-admitted patients

Pathology Queensland - Study, Education & Research Trust Fund

Open grant - 2020 - 2022

The development of novel pharmacokinetic techniques to optimise treatment and reduce antimicrobial resistance for sexually transmitted infections (STIs). (2020 NHMRC Ideas Grant led by UoM)

University of Melbourne

Open grant - 2019 - 2021

Screening anti-fungal exposure in intensive care unit

European Society of Clinical Microbiology and Infectious Diseases Study Group Research Grant

Open grant - 2019 - 2021

Intraoperative lignocaine infusions: Development of an optimised infusion dosing regimen for obese patients (Led by MNHHS)

Metro North Hospital and Health Service

Open grant - 2019

Establishing UQ Centre for Clinical Research as the centre for Aerosol therapy in critical care by optimising particle size of aerosols for effective drug delivery.

UQ Major Equipment and Infrastructure

Open grant - 2019 - 2024

Novel dosing regimens to maximise antibiotic effectiveness for treatment of pneumonia in the intensive care unit

NHMRC Project Grant

Open grant - 2019 - 2020

Optimising the treatment of invasive infection in critically ill neonates, through application of an innovative microsampling approach

Metro North Hospital and Health Service

Open grant - 2019

Pharmacokinetic and statistical analysis of data from Screening Anti-Fungal Exposure in Intensive Care Units (SAFE-ICU) study

Metro North Hospital and Health Service

Open grant - 2018 - 2020

Measuring aspirin penetration into synovial fluid to assess its potential for prevention of prosthetic joint infection

Study, education and research trust account

Open grant - 2018 - 2019

An in vitro study of the stability of ceftolozane-tazobactam in elastomeric infusor devices for ambulatory care

South Metropolitan Health Service

Open grant - 2018 - 2025

A platform clinical trial approach to the management of Mycobacterium abscessus complex (MABSC)

NHMRC MRFF - Lifting Clinical Trials Registries Capacity

Open grant - 2018 - 2021

Advanced treatment of infectious diseases for critically ill children, through innovation in blood sampling

The Children's Hospital Foundation

Open grant - 2018

Antimicrobial pharmacokinetics in critically ill adults during sustained low efficiency dialysis (SLED)

Ottawa Hospital Research Institute

Open grant - 2018 - 2019

Can software optimise antibiotic dosing in critically ill patients?

Metro North Hospital and Health Service

Open grant - 2018

Effect of albumin resuscitation on drug pharmacokinetics in low protein and LPS challenged sheep

Royal Brisbane and Women's Hospital Foundation

Open grant - 2018 - 2019

Innovative blood sampling to reduce the burden of long-term treatment for kidney transplant recipients

Metro North Hospital and Health Service

Open grant - 2018

Ion Mobility Separation of Challenging Clinical Samples

UQ Major Equipment and Infrastructure

Open grant - 2018 - 2021

Lipopeptide antibiotics for XDR Gram-negative infections

NHMRC Development Grant

Open grant - 2018 - 2019

Nuclear medicine suite for animals

UQ Major Equipment and Infrastructure

Open grant - 2018 - 2019

Pharmacokinetic-pharmacodynamic substudy of patients with severe sepsis randomised to receive beta-lactam antibiotics by either intermittent or continuous infusion.

Metro North Hospital and Health Service

Open grant - 2018

Rapid characterisation of pathogens for personalised antimicrobial selection in critically ill patients

Metro North Hospital and Health Service

Open grant - 2017 - 2018

Assay development for therapeutic drug monitoring of ceftolozane-tazobactam

Merck Sharp & Dohme Australia

Open grant - 2017 - 2019

A prospective observational pharmacokinetic evaluation of the plasma and cerebrospinal fluid concentrations of a single dose ceftolozane/tazobactam in infected critically ill patients with an ...

Merck Sharp & Dohme Australia

Open grant - 2017 - 2021

BLING III: A phase III randomised controlled trial of continuous beta-lactam infusion compared with intermittent betalactam dosing in... (NHMRC Project Grant led by the University of New South Wales)

University of New South Wales

Open grant - 2017 - 2018

Does routine antibiotic administration in overweight women having elective caesarean section achieve therapeutic levels?

Metro North Hospital and Health Service

Open grant - 2017 - 2018

Pharmacokinetic-pharmacodynamic substudy of patients with severe sepsis randomised to receive beta-lactam antibiotics by either intermittent or continuous infusion

Royal Brisbane and Women's Hospital Foundation

Open grant - 2017 - 2021

Redefining antibiotic dosing to reduce bacterial resistance

NHMRC Practitioner Fellowships

Open grant - 2017 - 2018

Screening Anti-Fungal Exposure in Intensive Care Units: The SAFE-ICU study

Metro North Hospital and Health Service

Open grant - 2016 - 2018

Using a drop of blood to personalise antibiotic dosing in children and prevent antibiotic resistance

Ian Potter Foundation

Open grant - 2016

Pharmacokinetic/Pharmacodynamic (PK/PD) analysis of antimicrobials in renal replacement therapy (RRT) and septic shock

University Hospital of Nîmes

Open grant - 2016 - 2018

Single dose population pharmacokinetics of intravenous posaconazole in critically ill patients

Merck Sharp & Dohme Australia

Open grant - 2016 - 2019

An observational pharmacokinetic study of ceftolozane-tazobactam in intensive care unit patients with and without continuous renal replacement therapy

Merck Sharp & Dohme Australia

Open grant - 2016 - 2017

Does inhaled tobramycin distribute effectively into the lungs? A comparative study using radiolabelled tobramycin.

Royal Brisbane and Women's Hospital

Open grant - 2016 - 2019

Novel membrane-targeted antibiotics against drug-resistant Gram-positive bacterial infections

NHMRC Development Grant

Open grant - 2016

Optimising ceftriaxone dosing for critically ill patients with severe pneumonia

Royal Brisbane and Women's Hospital

Open grant - 2015 - 2021

Centre for REdefining antibiotic use to reDUce resistanCE and prolong the lives of antibiotics (REDUCE)

NHMRC Centres of Research Excellence

Open grant - 2015 - 2016

A preliminary investigation of the pharmacokinetics and pharmacodynamics of amikacin/fosfomycin combination against Acinetobacter baumannii using a dynamic in vitro hollow-fibre infection model

Cardeas Pharma Corporation

Open grant - 2015

Pharmacokinetic Australasian Collaborative

Intensive Care Foundation

Open grant - 2015

Addressing an unmet need by establishing a state-of-the-art translational model at UQ: The hollow fibre in vitro infection model

UQ Major Equipment and Infrastructure

Open grant - 2015

Incidence, risk factors, consequences and treatment of ventilated patients with nosocomial infection with pandrug resistant organisms in hospitals in Asia

UWA-UQ Bilateral Research Collaboration Award

Open grant - 2015

Optimising Benzylpenicillin dosing for critically ill patients with severe pneumonia

Royal Brisbane and Women's Hospital

Open grant - 2014 - 2021

Centre for Research Excellence in Advanced Cardio-respiratory Therapies Improving OrgaN Support (ACTIONS)

NHMRC Centres of Research Excellence

Open grant - 2014 - 2015

Dose optimisation of fluconazole in critically ill

Royal Brisbane and Women's Hospital

Open grant - 2014 - 2017

Innovative dosing approaches to maximise bacterial killing and prevent resistance in septic critically ill patients

NHMRC Project Grant

Open grant - 2014 - 2018

Randomised controlled study of an intense short course of optimised combination therapy versus conventional therapy for the management of Gram-negative bacteraemia

Merck Sharp & Dohme Australia Grant for Pharmacotherapeutics in Infectious Diseases

Open grant - 2014

Strenghtening the School of Medicine's position as a central coordinator of global pharmacokenetic studies in critically ill patients

UQ Major Equipment and Infrastructure

Open grant - 2013 - 2015

DALI - Defining Antibiotic Levels in Intensive care unit patients

University Hospital of Nîmes

Open grant - 2013 - 2016

NHMRC Career Development Fellowship (Clinical; Level 1): Antibiotic optimisation for severely ill patients

NHMRC Career Development Award

Open grant - 2013 - 2014

Pharmacokinetics of cephalosporin antibiotics in peritoneal dialysis with peritonitis

Royal Brisbane and Women's Hospital

Open grant - 2013

Antibiotic Absorption and Clearance during Renal Replacement Therapy: An ex vivo study

UQ Early Career Researcher

Open grant - 2013 - 2015

Are modern methods for aminoglycoside monitoring superior to existing approaches? A randomised controlled trial

Royal Brisbane and Women's Hospital

Open grant - 2013 - 2016

Robust antibiotic dosing for critically ill patients receiving renal replacement therapy

NHMRC Project Grant

Open grant - 2012 - 2015

A phase IIb randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis

NHMRC Project Grant

Open grant - 2012

Facilitating School of Medicine as a central coordinator of global pharmacokinetic studies in critically ill patients

UQ Major Equipment and Infrastructure

Open grant - 2012 - 2014

Non-Haemolytic Friulimicins for the Treatment of Multi-Drug Resistant Bacteria

NHMRC Project Grant

Open grant - 2012 - 2015

Pilot Study of pharmacokinetic and pharmacodynamic assessment of monotherapy versus combination therapy for the management of gram negative bacteraemia

Royal Brisbane and Women's Hospital

Open grant - 2012 - 2015

Prevention of Ventilator Associated Pneumonia by Inhaled Heparin

Australian and New Zealand Intensive Care Foundation

Open grant - 2011 - 2013

Microdialysis to monitor fluid shifts and predict organ failure in the systemic inflammatory response syndrome

UQ Collaboration and Industry Engagement Fund

Open grant - 2011 - 2013

Improving antibiotic dosing in critically ill patients with renal failure

UQ Foundation Research Excellence Awards - DVC(R) Funding

Open grant - 2011 - 2015

Membrane-targeted antibiotic for the treatment of skin and lung infections caused by drug resistant pathogens including MRSA, VISA, VRE and S pneumoniae

Wellcome Trust Seeding Drug Discovery

Open grant - 2011 - 2014

Effect of intravenous glutamine supplementation in trauma patients receiving enteral nutrition: A prospective double-blind randomised clinical trial

Royal Brisbane & Women's Hospital Research Foundation

Open grant - 2010 - 2011

Pilot RCT of continuous beta-lactam infusion compared with intermittent dosing in critically ill patients

Australian and New Zealand Intensive Care Foundation

Open grant - 2010 - 2012

Antibiotics in critically ill patients - dosage adjustments in renal failure and during continuous veno-venous haemodialysis

Viertel Foundation (Sylvia and Charles Viertel)

Open grant - 2010 - 2012

Infection and survival imperative - the need for antibiotic dose optimisation in critically ill patients receiving dialysis

Ramaciotti Foundation

Open grant - 2010 - 2012

Pharmacokinetics in continuous venovenous haemodiafiltration (CVVHDF) - using plasma and tissue antibiotic concentrations to optimise dosing of beta-lactam antibodies

Royal Brisbane & Women's Hospital Research Foundation

Open grant - 2009 - 2010

Infection imperative - the need for antibiotic dose optimisation in critically ill patients receiving dialysis

UQ New Staff Research Start-Up Fund

Open grant - 2009 - 2013

NHMRC Training (Postdoctoral) Fellowship: Improving antibiotic dosing in hospitalised patients

NHMRC Training (Postdoctoral) Fellowship

Open grant - 2009 - 2014

Assessment of the Microcirculation in Shocked Critically Unwell Patients during the first 24 hours of resuscitation

Royal Brisbane & Women's Hospital Research Foundation

Open grant - 2009 - 2011

Pharmacokinetics of Cephalothin, Vancomycin and Gentamicin Used for Antimicrobial Prophylaxis during elective abdominal aortic aneurysm surgery

Australian & New Zealand College of Anaesthetists

Open grant - 2009 - 2011

Glomerular Hyperfiltration in at risk patients on Admission to the Intensive Care Unit (GHAU) Study

Royal Brisbane & Women's Hospital Research Foundation

Open grant - 2009 - 2014

Inhaled Prophylactic-Heparin In Ventilator Associated Pneumonia Prevention Trial (IPHAPP)

Royal Brisbane & Women's Hospital Research Foundation

Open grant - 2008 - 2010

Antibiotic dosing in the at risk critically ill patient

NHMRC Project Grant

Open grant - 2008

Improved quantification of spatial and temporal changes in plasma and tissue drug levels and tissue pathology

NHMRC Equipment Grant

Open grant - 2006 - 2007

Pharmacokinetic Modelling of Various B-lactam Antibiotics in Critically-ill Patients using Microdialysis

Australian & New Zealand College of Anaesthetists

Open grant

View all 101 past funded projects View less

Supervision

Availability

Professor Jason Roberts is: : Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

##### Precision antimicrobial dosing in infected critically ill patients

Principal Advisor - Doctor Philosophy

##### Improving drug therapy for children with sepsis and life-threatening infections

Principal Advisor

Other advisors: Dr Sainath Raman - Doctor Philosophy

##### Perioperative pharmacokinetics of surgical antibiotic prophylaxis

Principal Advisor

Other advisors: Professor Jeffrey Lipman, Professor Andre Van Zundert - Doctor Philosophy

##### Establishing effective antibiotic and sedative dosing in paediatrics with extracorporeal therapies (including extracorporeal membrane oxygenation and renal replacement therapies)

Principal Advisor

Other advisors: Dr Hafiz Abdul-Aziz - Doctor Philosophy

##### Paediatric antibiotic pharmacokinetics and micro-sampling utility and in the paediatric intensive care

Principal Advisor

Other advisors: Dr Mark Coulthard, Professor Jeffrey Lipman, Dr Xin Liu, Dr Patty Mitre - Doctor Philosophy

##### In vitro evaluation of the impact of different durations of exposure of fast-acting antimicrobials in combination with beta-lactams

Associate Advisor

Other advisors: Dr Fekade Sime - Doctor Philosophy

##### Optimising Immunoglobulin Use and Outcomes

Associate Advisor

Other advisors: Dr Andrea Henden - Doctor Philosophy

##### Intraoperative lignocaine infusions: Development of an optimised infusion dosing regimen for obese patients.

Associate Advisor

Other advisors: Professor Victoria Eley - Doctor Philosophy

##### Pharmacodynamics of intermittent versus prolonged infusion of beta-lactam antibiotics in the treatment of Gram-negative bacterial pneumonia

Associate Advisor

Other advisors: Dr Fekade Sime - Doctor Philosophy

##### Centre of Research Excellence - REduce the burden of antimicrobial reSistance through oPtimal, persONalised Dosing (RESPOND)

Associate Advisor

Other advisors: Dr Fekade Sime - Doctor Philosophy

##### Designing and Implementing a Clinician-Led Protocol for Heparinisation Using Optimal Targets- anti Xa vs APTT

Associate Advisor

Other advisors: Associate Professor Jessica Schults, Associate Professor Jayesh Dhanani - Doctor Philosophy

##### Optimising the stability and dosing regimens of antibiotics for outpatient parenteral antibiotic therapy

Associate Advisor

Other advisors: Dr Fekade Sime

View all 12 current supervisions View less

Completed supervision

Doctor Philosophy

##### The Pharmacokinetics & Pharmacodynamics of Antimycobacterial Drugs in People with Cystic Fibrosis and Drug-Resistant Tuberculosis Infection

Principal Advisor

Other advisors: Professor Rachel Thomson, Professor Scott Bell - 2025

Doctor Philosophy

##### Suitability of ß-lactam and ß-lactamase inhibitor combinations for use in outpatient parenteral antimicrobial therapy

Principal Advisor

Other advisors: Dr Fekade Sime - 2025

Doctor Philosophy

##### Optimising Care of Critically Ill Patients Through Improved Antibiotic Dosing

Principal Advisor - 2024

Doctor Philosophy

##### Defining Optimal Dosing Regimens of Colistin and Polymyxin B in Malaysian Patient Populations

Principal Advisor

Other advisors: Dr Hafiz Abdul-Aziz, Dr Fekade Sime - 2023

Doctor Philosophy

##### Strategies to improve the use of antimicrobials in hospitalised Indonesian patients

Principal Advisor

Other advisors: Professor Jeffrey Lipman, Dr Hafiz Abdul-Aziz - 2022

Doctor Philosophy

##### Evaluation of combination antibiotic regimens for the treatment of multidrug-resistant Acinetobacter baumannii infections

Principal Advisor

Other advisors: Dr Fekade Sime - 2022

Doctor Philosophy

##### Microbiological evaluation of piperacillin/tazobactam versus meropenem against extended-spectrum ß-lactamase-producing Escherichia coli

Principal Advisor

Other advisors: Dr Fekade Sime - 2021

Doctor Philosophy

##### Optimising antimicrobial dosing in critically ill patients on extracorporeal membrane oxygenation (ECMO)

Principal Advisor

Other advisors: Professor Kiran Shekar, Dr Hafiz Abdul-Aziz - 2020

Doctor Philosophy

##### Optimisation of alternative antibiotic dosing regimens for maximal antibacterial activity and suppression of emergence of resistance

Principal Advisor

Other advisors: Dr Fekade Sime - 2019

Doctor Philosophy

##### Study of the disposition of nebulized tobramycin

Principal Advisor

Other advisors: Professor John Fraser, Associate Professor Jeremy Cohen - 2019

Doctor Philosophy

##### A pharmacokinetic/pharmacodynamic and clinical outcome evaluation of beta-lactam antibiotic therapeutic drug monitoring in critically ill patients

Principal Advisor

Other advisors: Professor Jeffrey Lipman - 2017

Doctor Philosophy

##### Improving antibiotic dosing in critically ill Australian Indigenous patients with severe sepsis

Principal Advisor

Other advisors: Professor Jeffrey Lipman - 2016

Doctor Philosophy

##### Translating Innovative Pharmacokinetic Sampling Techniques into Improved Antibiotic Dosing Regimens in Critically Ill Patients

Principal Advisor

Other advisors: Professor Jeffrey Lipman - 2016

Doctor Philosophy

##### Optimizing beta-lactam antibiotic dosing in critically ill patients: Prolonged infusion versus intermittent bolus administration

Principal Advisor

Other advisors: Dr Christine Staatz, Professor Jeffrey Lipman - 2015

Master Philosophy

##### Vancomycin-associated nephrotoxicity in the Critically-Ill

Principal Advisor

Other advisors: Professor Jeffrey Lipman - 2015

Doctor Philosophy

##### ß-lactam antibiotic pharmacokinetics during continuous venovenous haemofiltration in critically ill patients: Continuous infusion versus intermittent bolus administration

Principal Advisor

Other advisors: Professor Jeffrey Lipman - 2026

Doctor Philosophy

##### Evaluation of combination antibiotic regimens as carbapenem-sparing alternatives for ceftazidime/avibactam-resistant Enterobacterales infections

Associate Advisor

Other advisors: Dr Fekade Sime - 2024

Doctor Philosophy

##### The metabolic fate of infused citrate in the critically ill population undergoing continuous renal replacment therapy using regional citrate anticoagulation

Associate Advisor

Other advisors: Professor Bala Venkatesh - 2024

Doctor Philosophy

##### Optimising Antibiotic Dosing for Treatment of Nosocomial Central Nervous System Infections in Neurocritical Care Patients

Associate Advisor

Other advisors: Professor Jeffrey Lipman - 2024

Doctor Philosophy

##### Personalising Antimicrobial Therapy in Critically Ill Patients using Bayesian Dosing Software

Associate Advisor - 2023

Doctor Philosophy

##### Translating Microsampling Techniques into Improved Antimicrobial Dosing for Critically Ill Children

Associate Advisor

Other advisors: Professor Jeffrey Lipman - 2021

Doctor Philosophy

##### Advanced Oral Antibiotic Formulations

Associate Advisor

Other advisors: Professor Peter Cabot, Professor Amirali Popat, Dr Fekade Sime, Dr James Robert Falconer - 2017

Master Philosophy

##### Improving the quality of prescribing in elderly hospital inpatients: evaluating the effect of a clinical pharmacist on ward rounds

Associate Advisor - 2016

Doctor Philosophy

##### Sick Patients, Starved Circuits and Sticky Drugs: Understanding pharmacokinetics during extracorporeal membrane oxygenation to optimise drug dosing and improve patient outcomes

Associate Advisor

Other advisors: Professor John Fraser - 2016

Doctor Philosophy

##### An Investigation of the Pharmacokinetics of Piperacillin, Meropenem and Fluconazole in Critically Ill Obese Patients

Associate Advisor

Other advisors: Professor Jeffrey Lipman, Emeritus Professor Michael Roberts - 2014

Doctor Philosophy

##### Improving Antimicrobial Use In Critically Ill Patients

Associate Advisor

Other advisors: Professor Jeffrey Lipman - 2014

Doctor Philosophy

##### Dose optimisation of antibiotics during different forms of renal replacement therapy: focus on tissue and target site antibiotic concentrations

Associate Advisor

Other advisors: Associate Professor Robert Boots, Professor Jeffrey Lipman - 2012

Master Philosophy

##### Challenges in management of infections on a burn injury unit.

Associate Advisor

Other advisors: Professor Jeffrey Lipman

View all 28 completed supervisions View less

Media

Enquiries

Contact Professor Jason Roberts directly for media enquiries about:

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au

External profiles

View all links View less

Social media

Log in to Academic Portal to update your profile

Update my profile